secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aligos Therapeutics, Inc. (ALGS)
CIK:        0001799448
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001193125-24-196966
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aligos appoints Heather Preston and Margarita Chavez to Board
-------------------------------------------------------------

- Board expanded to seven directors; Preston and Chavez appointed as Class II directors through 2025 annual meeting.
- Dr. Preston will chair the Nominating Committee; Ms. Chavez joins the Audit Committee.
- Each receives $40k annual retainer (prorated) and an initial option for 120,000 shares.
- Chavez gets additional $7,500/yr for Audit; Preston gets $8,000/yr for Nominating chair (both prorated).
- Both entered standard indemnification agreements; no material relationships requiring disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799448/000119312524196966/0001193125-24-196966-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799448/000119312524196966/d875950d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-196966

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer